Wells Fargo & Company Dexcom Inc Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Dexcom Inc stock. As of the latest transaction made, Wells Fargo & Company holds 1,209,175 shares of DXCM stock, worth $107 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,209,175

Previous 1,388,992 12.95%

Holding current value

$107 Million

Previous $93.1 Million 1.02%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$65.68 - $81.01 $11.8 Million - $14.6 Million	-179,817 Reduced 12.95%	1,209,175 $94 Million
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $5.01 Million - $9.08 Million	78,213 Added 5.97%	1,388,992 $93.1 Million
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $4.23 Million - $5.39 Million	38,363 Added 3.01%	1,310,779 $149 Million
Q1 2024 May 10, 2024	SELL	$114.22 - $140.1 $4.95 Million - $6.07 Million	-43,322 Reduced 3.29%	1,272,416 $176 Million
Q4 2023 Feb 09, 2024	SELL	$75.49 - $124.16 $4.32 Million - $7.11 Million	-57,265 Reduced 4.17%	1,315,738 $163 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $12.5 Million - $20.1 Million	-145,566 Reduced 9.59%	1,373,003 $128 Million
Q2 2023 Aug 15, 2023	BUY	$112.47 - $130.98 $8.7 Million - $10.1 Million	77,349 Added 5.37%	1,518,569 $195 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $5.59 Million - $6.61 Million	-53,786 Reduced 3.6%	1,441,220 $167 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $483,706 - $698,237	-5,692 Reduced 0.38%	1,495,006 $169 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $9.11 Million - $11.2 Million	-119,306 Reduced 7.36%	1,500,698 $121 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $78.9 Million - $154 Million	1,160,901 Added 252.86%	1,620,004 $121 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $3.68 Million - $5.09 Million	39,065 Added 9.3%	459,103 $235 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $75.1 Million - $94.1 Million	-578,009 Reduced 57.91%	420,038 $226 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $3.55 Million - $4.77 Million	-33,309 Reduced 3.23%	998,047 $546 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $5.84 Million - $7.78 Million	-72,077 Reduced 6.53%	1,031,356 $440 Million
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $7.81 Million - $9.65 Million	92,100 Added 9.11%	1,103,433 $397 Million
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $3.32 Million - $4.45 Million	42,561 Added 4.39%	1,011,333 $374 Million
Q3 2020 Nov 05, 2020	SELL	$95.51 - $112.95 $4.75 Million - $5.62 Million	-49,716 Reduced 4.88%	968,772 $399 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $25.1 Million - $42.3 Million	-401,137 Reduced 28.26%	1,018,488 $413 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $67.8 Million - $107 Million	1,419,625 New	1,419,625 $382 Million

Others Institutions Holding DXCM

# of Institutions

1,085

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Dexcom Inc Transaction History